New insights into the role of GSK-3β in the brain: from neurodegenerative disease to tumorigenesis
Glycogen synthase kinase 3 (GSK-3) is a serine/threonine kinase widely expressed in various tissues and organs. Unlike other kinases, GSK-3 is active under resting conditions and is inactivated upon stimulation. In mammals, GSK-3 includes GSK-3 α and GSK-3β isoforms encoded by two homologous genes,...
Main Authors: | Shenjin Lai, Peng Wang, Jingru Gong, Shuaishuai Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
PeerJ Inc.
2023-12-01
|
Series: | PeerJ |
Subjects: | |
Online Access: | https://peerj.com/articles/16635.pdf |
Similar Items
-
GSK3α: An Important Paralog in Neurodegenerative Disorders and Cancer
by: Octavio Silva-García, et al.
Published: (2020-12-01) -
Multi-Loop Model of Alzheimer Disease: An Integrated Perspective on the Wnt/GSK3β, α-Synuclein, and Type 3 Diabetes Hypotheses
by: Nicholas G. Norwitz, et al.
Published: (2019-07-01) -
Morin attenuates tau hyperphosphorylation by inhibiting GSK3β
by: Eun Ji Gong, et al.
Published: (2011-11-01) -
Icariin, a natural flavonoid glucoside, inhibits neuroinflammation in mice with triple-transgenic Alzheimer’s disease by regulating the Akt/GSK-3β signaling pathway
by: Sichen Wu, et al.
Published: (2024-07-01) -
Memory formation in old age requires GSK-3β
by: Riki Koike, et al.
Published: (2021-01-01)